MOTS-c belongs to a research category discovered comparatively recently: mitochondrial-derived peptides (MDPs), short sequences encoded within mitochondrial DNA rather than the cell's nuclear genome. It's studied as a signaling molecule that appears to communicate metabolic status between mitochondria and the rest of the cell, which is the basis for most of the research interest in it.
What this doesn't mean: as a comparatively recently characterized peptide class, MOTS-c's literature is smaller and earlier-stage than most other compounds in this library. This entry maps an active research direction, not an established outcome.
External reference: MOTS-c on PubChem (CID 176489569)
| Property | Value |
|---|---|
| Sequence class | 16-residue mitochondrial-derived peptide |
| Genomic origin | Encoded in mitochondrial DNA (12S rRNA region), distinct from nuclear-encoded peptides |
| Solubility | Water-soluble; typically reconstituted with sterile or bacteriostatic water in lab settings |
| Stability notes | Standard lyophilized-peptide handling precautions apply |
Figures summarize commonly cited characteristics in the research literature and are provided for reference only — always consult the certificate of analysis (COA) for a specific research batch.
MOTS-c follows standard lyophilized-peptide handling: frozen or refrigerated storage prior to reconstitution, protection from light and moisture, and limited freeze-thaw cycling once dissolved. See Protocols for general laboratory practices.
Batch-tested MOTS-c for laboratory research use is available through Ascend Amino, including lot-specific certificates of analysis. Research use only — not for human or veterinary use.
For background on metabolic-research peptides more broadly, see the Science Hub, or compare against Semaglutide and Retatrutide, which target metabolic pathways through a different, receptor-based mechanism.